Biocartis Group NV: Biocartis and GeneproDx to collaborate on fully automated thyroidPrint test on Idylla
Biocartis and GeneproDx to collaborate on fully automated ThyroidPrint test on Idylla
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Nov 20
Biocartis and GeneproDx to collaborate on fully automated ThyroidPrint test on Idylla
04 Nov 20
With the authorisation, ORAcollect·RNA is allowed to be used as unsupervised sample collection device along with an approved…
04 Nov 20
The acquisition is expected to enhance Resonetics' capabilities as a specialised manufacturer of medical device components
04 Nov 20
The components are equipped with a valve, that when activated, forms an airtight seal between the male luer…
04 Nov 20
TheraCell completes first three surgical cases with the TheraFuze DBF Fiber Anchor offering surgeons improved screw fixation and…
04 Nov 20
The Stop'n GO Double Balloon Catheter (Quattroplasty) and accompanying specialized instrumentation are FDA approved and available to physicians…
03 Nov 20
The acquisition will allow Olympus to expand distribution of its orthopaedic products through FH ORTHO’s existing channels
03 Nov 20
Under the terms of the agreement, GeneproDx will take the lead in the development of the Idylla ThyroidPrint…
03 Nov 20
The INSTI HIV Self Test is part of bioLytical’s world-leading line of 1-minute tests for infectious diseases including…
03 Nov 20
MaxView is a state-of-the-art technology that enables high definition, intraoperative visualization and easily integrates into spine procedures for…